Cooper PE Ratio 2010-2025 | COO

Current and historical p/e ratio for Cooper (COO) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Cooper PE ratio as of June 02, 2025 is 17.60.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Cooper PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-06-02 67.00 32.52
2025-01-31 96.55 $2.06 46.87
2024-10-31 104.68 $1.95 53.68
2024-07-31 93.33 $1.80 51.99
2024-04-30 89.06 $1.70 52.31
2024-01-31 93.26 $1.46 63.77
2023-10-31 77.94 $1.48 52.75
2023-07-31 97.82 $1.38 70.75
2023-04-30 95.36 $1.45 65.76
2023-01-31 87.23 $1.89 46.21
2022-10-31 68.34 $1.94 35.22
2022-07-31 81.74 $2.16 37.80
2022-04-30 90.24 $4.76 18.96
2022-01-31 99.55 $4.71 21.12
2021-10-31 104.20 $14.81 7.03
2021-07-31 105.41 $14.67 7.18
2021-04-30 102.68 $11.86 8.66
2021-01-31 90.97 $11.33 8.03
2020-10-31 79.72 $1.20 66.30
2020-07-31 70.70 $1.40 50.59
2020-04-30 71.63 $1.72 41.71
2020-01-31 86.67 $2.27 38.14
2019-10-31 72.70 $2.34 31.14
2019-07-31 84.29 $2.24 37.72
2019-04-30 72.42 $2.14 33.80
2019-01-31 69.64 $1.84 37.90
2018-10-31 64.52 $0.70 92.84
2018-07-31 65.07 $0.64 102.47
2018-04-30 57.12 $0.65 87.88
2018-01-31 61.11 $0.87 70.04
2017-10-31 60.00 $1.88 31.91
2017-07-31 60.90 $1.74 34.95
2017-04-30 50.02 $1.67 30.00
2017-01-31 46.10 $1.52 30.38
2016-10-31 43.95 $1.40 31.45
2016-07-31 45.55 $1.28 35.66
2016-04-30 38.21 $1.06 36.13
2016-01-31 32.74 $0.99 33.23
2015-10-31 38.02 $1.04 36.73
2015-07-31 44.17 $1.01 43.95
2015-04-30 44.43 $1.23 36.19
2015-01-31 39.33 $1.33 29.69
2014-10-31 40.89 $1.38 29.63
2014-07-31 40.13 $1.51 26.58
2014-04-30 32.90 $1.51 21.82
2014-01-31 31.00 $1.48 20.91
2013-10-31 32.22 $1.49 21.62
2013-07-31 31.75 $1.57 20.26
2013-04-30 27.52 $1.46 18.85
2013-01-31 25.27 $1.36 18.58
2012-10-31 23.92 $1.27 18.91
2012-07-31 18.76 $1.19 15.79
2012-04-30 21.96 $1.04 21.07
2012-01-31 17.97 $0.95 19.02
2011-10-31 17.26 $0.91 19.07
2011-07-31 19.05 $0.88 21.77
2011-04-30 18.64 $0.90 20.83
2011-01-31 14.27 $0.74 19.35
2010-10-31 12.28 $0.61 20.21
2010-07-31 9.67 $0.52 18.77
2010-04-30 9.67 $0.42 23.02
2010-01-31 8.78 $0.53 16.57
2009-10-31 6.96 $0.55 12.59
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $13.655B $3.895B
The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $90.020B 21.74
Becton Dickinson (BDX) United States $49.466B 12.25
Cardinal Health (CAH) United States $36.861B 19.31
Labcorp (LH) United States $20.839B 16.90
Straumann Holding AG (SAUHY) Switzerland $20.586B 0.00
West Pharmaceutical Services (WST) United States $15.149B 31.75
Align Technology (ALGN) United States $13.115B 26.03
Henry Schein (HSIC) United States $8.519B 14.61
Merit Medical Systems (MMSI) United States $5.616B 27.15
DENTSPLY SIRONA (XRAY) United States $3.185B 9.51
CONMED (CNMD) United States $1.756B 13.14
STAAR Surgical (STAA) United States $0.882B 0.00
Lifevantage (LFVN) United States $0.164B 16.95
Pro-Dex (PDEX) United States $0.131B 14.30